scispace - formally typeset
W

Wei Hu

Researcher at University of Science and Technology of China

Publications -  24
Citations -  580

Wei Hu is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 113 citations.

Papers
More filters
Journal ArticleDOI

Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.

Xinfeng Liu, +87 more
- 01 Feb 2020 - 
TL;DR: There was no evidence of a difference in favourable outcomes of patients receiving endovascular therapy compared with those receiving standard medical therapy alone, and the trial was terminated early after 131 patients had been randomly assigned because of high crossover rate and poor recruitment.
Journal ArticleDOI

Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion.

TL;DR: In a trial involving Chinese patients with basilar-artery occlusion, approximately one third of whom received intravenous thrombolysis, endovascular thrombectomy within 12 hours after stroke onset led to better functional outcomes at 90 days than best medical care but was associated with procedural complications and intracerebral hemorrhage.
Journal ArticleDOI

Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.

TL;DR: Among patients with large vessel occlusion acute ischemic stroke undergoing endovascular thrombectomy, treatment with intravenous tirofiban, compared with placebo, before endov vascular therapy resulted in no significant difference in disability severity at 90 days.
Journal ArticleDOI

Endovascular treatment for acute basilar artery occlusion: A multicenter randomized controlled trial (ATTENTION)

TL;DR: The investigator-initiated ATTENTION will provide evidence for the efficacy and safety of EVT in stroke patients within 12 h after BAO, with a modified Rankin Score of 0–3 at day 90.